| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.03 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.065 | 0.03 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.36 | 0.04 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.063 | 0.04 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.094 | 0.04 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.094 | 0.05 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.05 |